Analysed METAVIA INC (MTVA:NASDAQ) News Sources
MetaVia Doses the First Patient in Higher-Dose Phase 1 Study of DA-1726, Its GLP-1 and Glucagon Dual Agonist for the Treatment of Obesity
10-04-2026
yahoo.com
MTVA: Phase 1 Part 3 16-Week Titration Study of DA-1726 to Initiate in April 2026…
31-03-2026
yahoo.com
OTC Markets Hosts Virtual Investor Presentation with H.H. Kim, CEO and President of MetaVia, and David Bautz, PhD, Senior Analyst at Zacks SCR
19-03-2026
yahoo.com
MetaVia Advances GLP-1-Based Obesity Program with IRB Approval for Higher-Dose Phase 1 Studies of DA-1726, a GLP-1 and Glucagon Dual Agonist Demonstrating Best-in-Class Potential for Weight Loss and Glucose Control
18-03-2026
yahoo.com
Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing
13-03-2026
yahoo.com
MetaVia Expands Global Patent Protection for Vanoglipel, Supporting Metabolic and Liver Disease Therapy Through 2035
12-03-2026
yahoo.com
MetaVia to Highlight Novel Obesity and Metabolic Therapies at Upcoming Life Sciences Virtual Investor Forum
04-03-2026
yahoo.com
What is the current price of METAVIA INC (MTVA:NASDAQ)?
The current price of METAVIA INC (MTVA:NASDAQ) is $1.41.
METAVIA INC (MTVA:NASDAQ) absolute price change since previous trading day?
The absolute price change of METAVIA INC (MTVA:NASDAQ) since the previous trading day is $0.22.
METAVIA INC (MTVA:NASDAQ) percentage price change since previous trading day?
The percentage price change of METAVIA INC (MTVA:NASDAQ) since the previous trading day is 18.4874%.
What is the most recent average sentiment score for METAVIA INC (MTVA:NASDAQ)?
The most recent average sentiment score for METAVIA INC (MTVA:NASDAQ) is 83 out of 100.
What is the most recent average sentiment for METAVIA INC (MTVA:NASDAQ)?
The most recent sentiment for METAVIA INC (MTVA:NASDAQ) is .
SEC-8K** Filing Available For METAVIA INC (MTVA:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.